Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Study confirms electrical storm as potent risk factor for death and impaired quality of life

Electrical storm (ES) is a potent risk factor for mortality and morbidity, according to research presented today at the ESC Congress 2012 by Dr Federico Guerra from Italy. Data was also presented on which patients are prone to developing ES and how effective current treatments are.

27 Aug 2012

Cardiovascular screening with ECG in young athletes is cost effective

Cardiovascular screening with ECG in young athletes is a cost effective way of diagnosing cardiac abnormalities, at just 138 Swiss Francs (about €115) per athlete. The findings were presented today at the ESC Congress 2012 by Dr Andrea Menafoglio from Switzerland.

27 Aug 2012

UI Hospital receives Medtronic Foundation grant to coordinate Illinois Heart Rescue

The University of Illinois Hospital and Health Sciences System has received a $2.5 million grant from the Medtronic Foundation to coordinate Illinois Heart Rescue, an ambitious statewide all-volunteer effort to more than double survival from sudden cardiac arrests in Illinois.

From Medtronic 22 Aug 2012

RasGas establishes heart safe workplace with installation of LIFEPAK CR Plus AEDs

Physio-Control, Inc., a provider of emergency medical response solutions worldwide, today announced that global energy supplier RasGas Company Limited (RasGas) has established a heart safe workplace with the installation of LIFEPAK CR Plus automated external defibrillators (AEDs).

22 Aug 2012

CHD patients do not need to rule out high-intensity exercise

Findings from a retrospective study show that patients with coronary heart disease who engage in high-intensity exercise have a similarly low risk for a cardiovascular event as those engaging in moderate-intensity exercise.

21 Aug 2012

FDA approved drug to treat Ph- acute lymphoblastic leukemia

The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.

10 Aug 2012

ICD use contributes to decline in cardiac arrest

Implantable cardioverter defibrillator use is responsible for one-third of the decline in cardiac arrests caused by ventricular fibrillation, researchers say.

9 Aug 2012

Old cardiac drug performs new tricks

An animal study has shown that the anti-angina drug ranolazine could significantly reduce the number of deaths from carbon monoxide poisoning.

8 Aug 2012

Common anti-angina drug may help protect the heart against carbon monoxide poisoning

An international research team, led from the University of Leeds, has found that a common anti-angina drug could help protect the heart against carbon monoxide poisoning.

6 Aug 2012

Survey results of adoption and implementation of therapeutic hypothermia in hospitals

National guidelines recommend the use of therapeutic hypothermia to improve outcomes in patients who suffer a heart attack outside of a hospital. The results of a survey of all 73 acute care hospitals in New Jersey evaluating the adoption and implementation of this life-saving treatment from 2004-2011 is published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

3 Aug 2012

‘Fifth link’ improves outcomes after out-of-hospital cardiac arrest

Neurologic outcomes for survivors of out-of-hospital cardiac arrest are significantly improved after implementation of the 2010 American Heart Association's fifth link in the chain-of-survival concept for postresuscitation care, show Japanese study results.

3 Aug 2012

Fifth link to complete chain for cardiac arrest care?

Adding a fifth link to the “Chain of Survival” concept for management of patients with out-of-hospital cardiac arrest significantly improves their survival and positive neurologic outcome chances, a study suggests.

31 Jul 2012

'Fifth link' associated with increase in survival rate among survivors of sudden cardiac arrest

Fewer sudden cardiac arrest survivors had neurologic impairment after a novel regional system of care was implemented, according to research published in Circulation, an American Heart Association journal.

31 Jul 2012

Congenital long QT syndrome guidelines ‘too restrictive’

Athletes who choose to continue competing after being diagnosed with long QT syndrome have a low rate of LQTS-triggered cardiac events, US researchers report.

26 Jul 2012

Study uses photodynamic therapy to ablate cardiac myocytes responsible for arrhythmias

University of Michigan heart researchers are shedding light on a safer method for steadying an abnormal heart rhythm that prevents collateral damage to healthy cells.

25 Jul 2012

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.

21 Jul 2012

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Kyprolis (carfilzomib) for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.

21 Jul 2012

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Study confirms electrical storm as potent risk factor for death and impaired quality of life

Cardiovascular screening with ECG in young athletes is cost effective

UI Hospital receives Medtronic Foundation grant to coordinate Illinois Heart Rescue

RasGas establishes heart safe workplace with installation of LIFEPAK CR Plus AEDs

CHD patients do not need to rule out high-intensity exercise

FDA approved drug to treat Ph- acute lymphoblastic leukemia

ICD use contributes to decline in cardiac arrest

Old cardiac drug performs new tricks

Common anti-angina drug may help protect the heart against carbon monoxide poisoning

Survey results of adoption and implementation of therapeutic hypothermia in hospitals

‘Fifth link’ improves outcomes after out-of-hospital cardiac arrest

Fifth link to complete chain for cardiac arrest care?

'Fifth link' associated with increase in survival rate among survivors of sudden cardiac arrest

Congenital long QT syndrome guidelines ‘too restrictive’

Study uses photodynamic therapy to ablate cardiac myocytes responsible for arrhythmias

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

Light reflexes during CPR may indicate survival chances

Prediction tool indicates prognosis after cardiac arrest

Signs that a child is seriously ill: Interview with Professor Middleton

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in